Navigation Links
Selexys Pharmaceuticals Initiates Enrollment in Phase I Clinical Study of SelG1
Date:5/4/2011

OKLAHOMA CITY, May 4, 2011 /PRNewswire/ -- Selexys Pharmaceuticals announced today that it has initiated enrollment in a Phase I clinical study of its lead compound, SelG1, a humanized anti-P-selectin antibody.  

The placebo-controlled, double-blind, first-in-human, ascending single dose and multiple dose study of SelG1 will enroll approximately 30 healthy subjects. This study will evaluate the safety and pharmacology of SelG1 prior to advancement into a Phase II trial in patients with sickle cell disease.

"This Phase I study represents the first step in understanding the potential of SelG1 to address the unmet medical need in sickle cell disease and we are excited to initiate the clinical development of this novel compound," said Dr. Scott Rollins, Selexys President and CEO. "This Phase I trial represents a key milestone for Selexys as we transition from a preclinical to a clinical development stage biopharmaceutical company."

In 2008, Selexys received orphan-drug designation for SelG1 from the Food and Drug Administration Office of Orphan Products Development for the treatment of vasoocclusive crisis, a severe and painful complication of sickle cell disease. Orphan drug designation is awarded to therapeutics with the potential for safe and effective treatment diagnosis or prevention of rare diseases and disorders that affect fewer than 200,000 people.

About SelG1

SelG1 is an investigational humanized monoclonal antibody directed against P-selectin, a key member of the adhesion molecule family known as the selectins. In preclinical studies, inhibition of P-selectin has been shown to effectively prevent vasoocclusion by blocking critical cell-cell interactions that drive this process. Therapeutic blockade of P-selectin may therefore reduce vasoocclusion and subsequent crises in patients with sickle cell disease.

"SelG1 represents a first-in-class therapeutic approach for the treatment of sickle cell disease
'/>"/>

SOURCE Selexys Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Aires Pharmaceuticals Appoints Edwin L. Parsley as Chief Medical Officer
2. Keryx Biopharmaceuticals, Inc. Prices Common Stock Offering
3. MHPA Center for Best Practices Receives Sponsorship from Ortho-McNeil Janssen Pharmaceuticals, Inc. to Improve Medicaid Quality, Care Coordination for Serious Mental Illness
4. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
5. Auxilium Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
6. Onyx Pharmaceuticals Reports First Quarter 2011 Financial Results
7. Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2011 Financial Results Webcast and Conference Call
8. Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update
9. Jazz Pharmaceuticals Announces First Quarter 2011 Financial Results
10. Idenix Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
11. Isis Pharmaceuticals to Present at the 14th Annual Bank of America Merrill Lynch Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)...  Unilife Corporation ("Unilife" or the "Company") (NASDAQ: ... supplier of injectable drug delivery systems, today announced the ... Company with flexibility and control to support its continued ... equity purchase agreement for up to $45 million with ... Chicago -based institutional investor, which provides the Company ...
(Date:7/29/2015)... , July 29, 2015  According to data ... Services, the 2016 average monthly Medicare Part D premium ... far lower than was originally projected, the Pharmaceutical Care ... D program continues to be a bright spot in ... choices in each region and using cutting edge, cost-saving ...
(Date:7/29/2015)... and CAMBRIDGE, Mass. , ... ISIS ), the leader in RNA-targeted therapeutics, ... today that The New England Journal of ... 2 clinical study evaluating volanesorsen (formerly ISIS-APOCIII Rx ... high triglycerides. This publication follows the December 2014 ...
Breaking Medicine Technology:Unilife Announces Multifaceted Financing Strategy 2Unilife Announces Multifaceted Financing Strategy 3Unilife Announces Multifaceted Financing Strategy 4Unilife Announces Multifaceted Financing Strategy 5Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 2Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 3Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 4Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 5Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 6Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 7
... , CHICAGO, Nov. 30 Dr. Jocelyn ... George Washington University Medical Center in Washington, D.C., demonstrated ... can be localized utilizing multi-modality imaging for needle biopsy ... annual meeting of the Radiological Society of North America ...
... , BOZEN, Italy, ... development plans and product specifications,for a new and revolutionary concept: "Totally ... the Future vision to be,showcased at Las Vegas, ASHP (Booth # ... the reaction from our customers to the,TPNstation,s blueprints and to find ...
Cached Medicine Technology:Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3
(Date:7/30/2015)... Hills, CA (PRWEB) , ... July 30, 2015 , ... ... of the Argus II retinal implant, more commonly known as the “bionic eye,” researchers ... as a safe and viable tool for patients facing or already affected by complete ...
(Date:7/30/2015)... ... ... presentation of the 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) ... Arthroplasty pertaining to how soon after undergoing hip replacement surgery (THR) patients are able ... Santa Rosa Orthopaedics (SRO) surgeon Nathan Ehmer D.O . is seeing in ...
(Date:7/30/2015)... New York, NY (PRWEB) , ... July 30, ... ... to highlight the right and necessity for women to ensure their children have ... healthy development of children from pre-birth by offering discount cards for many prescription ...
(Date:7/29/2015)... Plano, TX (PRWEB) , ... July 30, 2015 ... ... best content available for their clients, BOC approved provider of online continuing ... six new course offerings to their exclusive Andrews Research and Education Sports Medicine ...
(Date:7/29/2015)... ... , ... Avatar Solutions has received official approval from CMS to administer the ... CAHPS for PQRS Survey collects information about patients’ experiences of care within the ... or they will receive a 2% penalty in 2017. At this point in time, ...
Breaking Medicine News(10 mins):Health News:The Vision Enhancing “Bionic Eye” Deemed Safe For Long Term Use After Three Year Clinical Trial 2Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 2Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 2Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 4Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 3Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 3
... glutamate, which occurs naturally in the brain as a byproduct of ... ... (Vocus) April 30, 2009 -- UCSF researchers have identified ... the brain as a byproduct of metabolism, and greater disease burden ...
... reform and the range of options being promoted, CodeBlueNow! a nonpartisan nonprofit ... ... WA (PRWEB) April 30, 2009 -- CodeBlueNow!, a nonpartisan, nonprofit seeking to ... guide to the language and key elements of health care reform. ...
... program consisting of one counseling session and two follow-up ... correctly performing breast self- exams. These are the findings of ... American Journal of Health Promotion . , Funded ... the first to show intervention programs can be effective in ...
... on others, at expense of their own mental health ... American women interviewed for a survey released today by ... sagging economy has negatively affected their lives or the ... women may be neglecting their own needs while focusing ...
... Kaiser Permanente lead author recommends comprehensive approach to management ... women with asthma, the most common condition affecting the ... asthma in order to optimize the health of mother ... in the current issue of the New England ...
... 29 Reaching optimal levels for cholesterol and high blood ... prevent a second stroke or heart attack, according to a ... Program at the American Academy of Neurology,s 61st Annual Meeting ... four risk factors for stroke: high LDL cholesterol, low HDL ...
Cached Medicine News:Health News:Glutamate Identified As Predictor of Disease Progression in Multiple Sclerosis 2Health News:Glutamate Identified As Predictor of Disease Progression in Multiple Sclerosis 3Health News:New Health Care Reform Glossary Published 2Health News:Women 10 times more likely to do breast self-exams correctly with intervention, KP study finds 2Health News:Women's Mental Health Hit Hard by Recession, Yet Many Show Resilience and Resourcefulness in Coping With Stress 2Health News:Women's Mental Health Hit Hard by Recession, Yet Many Show Resilience and Resourcefulness in Coping With Stress 3Health News:Women's Mental Health Hit Hard by Recession, Yet Many Show Resilience and Resourcefulness in Coping With Stress 4Health News:Management of Asthma During Pregnancy Can Optimize Health of Mother and Baby, According to Recommendations 2Health News:Management of Asthma During Pregnancy Can Optimize Health of Mother and Baby, According to Recommendations 3Health News:Management of Asthma During Pregnancy Can Optimize Health of Mother and Baby, According to Recommendations 4Health News:Controlling Cholesterol, Blood Pressure Adds Up to Prevent Stroke 2
High temp cauteries, fine tip micro....
Strongly curved 90 degree, working part 200 mm....
Aaron 2250 is a multipurpose electrosurgical generator with monoploar and bi-polar functions....
Sabre 180 is a powerful niche generator....
Medicine Products: